Laboratory News and Research

RSS

New antibody-specific AI framework accelerates discovery of therapeutic drugs

Designing an effective antibody drug is like searching for the right key in a warehouse of locks. Scientists may begin with millions-or even billions-of antibody candidates, but only a tiny fraction will recognize and bind tightly to the disease target.

13 Aug 2026

Sino Biological launches European newsletter campaign with exclusive welcome gifts

Sino Biological has launched a special Newsletter Registration Campaign exclusively for customers in Europe, offering researchers and life science professionals an exciting opportunity to stay connected with the latest scientific updates while receiving a complimentary welcome gift, which may be an adorable Snail Plushie Set or an Amazon Gift Card.

From Sino Biological Inc. 13 Aug 2026

Automated MRI system improves improves evaluation of experimental stroke therapies

Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have developed an automated system that uses MRI to measure brain tissue changes in animal models for large, multicenter studies of experimental stroke treatments.

12 Aug 2026

Personalized T-cell therapy eliminates advanced kidney tumor in teenager

Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor.

12 Aug 2026

AI-based methods help uncover hidden roots of tumor metastasis

A cancerous tumor is not a single enemy. It is made up of many different cell populations that can behave in very different ways.

12 Aug 2026

Mitochondrial gene RTN4IP1 drives triple-negative breast cancer metastasis

Triple-negative breast cancer accounts for approximately 15% of all breast cancer cases. It is characterized by the absence of estrogen receptor, progesterone receptor, and HER2 expression, rendering it insensitive to conventional endocrine and targeted therapies.

12 Aug 2026

Researchers find unexpected protein regulator of leukemia drug sensitivity

How cells respond to the leukemia drug 6-thioguanine still holds surprises: A new study, led by researchers from CeMM and the University of Oxford identifies NUDT5 as an unexpected regulator of drug sensitivity and reveals that its role has nothing to do with its enzymatic activity.

12 Aug 2026

Researchers develop noninvasive chairside test to detect oral cancer

A Case Western Reserve University–led research team is developing a noninvasive oral cancer test to help clinicians decide-chairside and within minutes- whether a suspicious lesion in the mouth needs a biopsy.

12 Aug 2026

New open source tool unifies fragmented global lipid databases

In collaboration with the University of Vienna, the Technical University of Munich (TUM), and Heidelberg University, researchers at the TUD Dresden University of Technology have developed an innovative tool that significantly simplifies lipid research.

12 Aug 2026

Laboratory chemical exposure and poor diet increase odds of health symptoms in young scientists

Young scientists who frequently handle laboratory chemicals and consume relatively few antioxidant-rich foods may be more likely to report symptoms such as fatigue, headaches, pallor, and easy bruising, according to a new study of university students in Nigeria.

12 Aug 2026

Bruker announces strategic collaboration with Atinary Technologies to advance Self-Driving Laboratories

Bruker Corporation today announced an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs® technologies and AI-driven R&D with applications in pharmaceuticals, chemicals, energy, and materials.

From SciY 12 Aug 2026

CN Bio awarded Innovate UK grant to reduce animal use in pharmacokinetic studies

CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced it has been awarded £180 k grant funding from Innovate UK.

From CN Bio 12 Aug 2026

Cannabis compounds may weaken glioblastoma response to chemotherapy and radiation

Several cannabinoids reduced chemotherapy- and radiation-induced apoptosis in glioblastoma cell models, with effects linked to reduced apoptotic priming, increased pro-survival signaling, and G1 cell-cycle arrest. The findings raise concern that cannabinoid exposure could interfere with some cancer treatments, although the results are limited to laboratory models and require in vivo and clinical validation.

12 Aug 2026

Study: Nearly all personal care and cleaning products contain undisclosed chemicals

A new study of sunscreens, baby lotions, shampoos, soaps, and other everyday products found that nearly all contained chemicals not disclosed on their labels.

11 Aug 2026

Nocturnal micro-awakenings linked to genetic risk of Alzheimer's disease

What if certain signs of the disease were to manifest themselves subtly during sleep, long before the first memory problems appear? This is the line of inquiry being explored by a team of researchers at ULiège, with the support of the Stop Alzheimer's Foundation.

11 Aug 2026

Aston University study reveals how mānuka honey fights antibiotic resistance

New research at Aston University has shown that a variety of compounds is responsible for the antimicrobial action of mānuka honey, not just the sugar content and methylglyoxal (MGO) alone, as previously thought.

11 Aug 2026

New computational tool identifies hidden genes driving asthma

Researchers at Columbia University Mailman School of Public Health, in collaboration with investigators at the University of Chicago, have developed a new computational framework that helps scientists identify genes that play central roles in diseases such as asthma but are often overlooked by existing genetic analysis methods.

11 Aug 2026

New UH Health initiative targets Texas healthcare workforce shortage

Addressing Texas' growing healthcare workforce shortage and rising demand for care, the University of Houston has launched UH Health, an academic health enterprise designed to integrate education, research and community engagement across the University.

11 Aug 2026

New dashboard tracks flesh-eating screwworm threat across the United States

In the 1950s, the New World screwworm cost U.S. livestock producers tens of millions of dollars a year, as much as $50 to $100 million annually in the hardest-hit Southwest, before it was eradicated from the United States and pushed south to Panama.

11 Aug 2026

New review urges proteostatic fitness standards for stem cell therapies

Stem cell therapies have expanded rapidly, with more than 115 clinical trials involving over 1,200 patients approved by late 2024. The U.S. Food and Drug Administration (FDA) recently approved Ryoncil (remestemcel‑L) for children with steroid‑refractory acute graft‑versus‑host disease, signaling a major shift toward routine clinical use.

11 Aug 2026